Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Tango Therapeutics (TNGX) over the last 4 years, with Q3 2025 value amounting to $1.3 million.

  • Tango Therapeutics' Treasury Shares rose 655.28% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 655.28%. This contributed to the annual value of $1.2 million for FY2024, which is 5964.5% up from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Treasury Shares is $1.3 million, which was up 655.28% from $1.4 million recorded in Q2 2025.
  • Tango Therapeutics' 5-year Treasury Shares high stood at $1.5 million for Q1 2025, and its period low was $633626.0 during Q1 2023.
  • For the 3-year period, Tango Therapeutics' Treasury Shares averaged around $1.1 million, with its median value being $1.2 million (2024).
  • In the last 5 years, Tango Therapeutics' Treasury Shares skyrocketed by 9798.05% in 2024 and then soared by 655.28% in 2025.
  • Tango Therapeutics' Treasury Shares (Quarter) stood at $757514.0 in 2023, then soared by 59.64% to $1.2 million in 2024, then grew by 5.66% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.4 million for Q2 2025, and $1.5 million during Q1 2025.